Please find enclosed herewith the Non- Applicability of Disclosure of Large Corporate for the financial year 31st March, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Boston Bio Systems Limited has informed BSE that it does not qualify as a 'Large Corporate' under the criteria specified in SEBI's circulars on fund-raising through debt securities by large entities. As a result, the company is exempted from submitting the additional large-corporate disclosures that would otherwise be required for the financial year ended 31st March 2025. The filing was signed by Director Ghanshyam Dhananjay Gavali (DIN: 03343352) on 14th May 2025 and is purely a routine compliance confirmation.
No material impact on shareholders or the stock price — this is a routine regulatory disclosure confirming that the company is small enough to be exempt from certain debt-issuance reporting requirements.